artesunic acid has been researched along with Orphan Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, PJ; Kreeftmeijer-Vegter, AR; van Veldhuizen, CK | 1 |
| Abdullah, HM; Qadir, S; Shahzad, MA; Ullah, W | 1 |
2 other study(ies) available for artesunic acid and Orphan Diseases
| Article | Year |
|---|---|
Roll out of intraveneous artesunate under named patient programmes in the Netherlands, Belgium and France.
Topics: Administration, Intravenous; Antimalarials; Artemisinins; Artesunate; Belgium; France; Humans; Malaria; Netherlands; Rare Diseases | 2013 |
Haemophagocytic lymphohistiocytosis (HLH): a rare but potentially fatal association with Plasmodium vivax malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Humans; Lymphohistiocytosis, Hemophagocytic; Malaria, Vivax; Male; Rare Diseases; Treatment Outcome; Young Adult | 2016 |